Neilanjan Nandi, MD, FACG, AGAF, FACP
Gastroenterology
Accepting new patients
Sees patients age 18 and up
Penn Digestive and Liver Health Center University City
View 2 additional locations
Make an appointmentCall 800-789-7366
Headshot of Neilanjan Nandi, MD, FACG, AGAF, FACP
Penn Medicine Provider

About me

  • Co-Section Head and Clinical Program Director, Penn Inflammatory Bowel Diseases Program
  • Associate Professor of Clinical Medicine (Gastroenterology)

Education and training

  • Medical School: Northwestern University Feinberg School of Medicine
  • Residency: Thomas Jefferson University Hospital
  • Fellowship: Jackson Health System - Jackson Memorial

What my patients think about me

Average Rating

534 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
dr. nandi really listens to my questions and concerns. he in very knowledgeable and answered all my questions.
Anonymous
April 2026
dr nandi takes time to discuss patients concerns
Anonymous
April 2026
he is so caring and attentive and just wonderful!
Anonymous
April 2026
to have a disease that needs to be maintained with meds your entire life is serious and can be scary. dr nandi it's always honest. he will do what's best for his patients and always makes me feel as if i'm not alone in the fight against gastro issues. he advocates for his patients. they're not many doctors left to do this.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Nandi is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Tina Aswani-Omprakash, Jalpa Devi, Madhura Balasubramaniam, Ashwin N. Ananthakrishnan, Neilanjan Nandi, Parakkal Deepak, Shaji Sebastian, Sumit Bhatia, Smruti Govan, Vishal Sharma, Kiran Peddi, Tauseef Ali, Reezwana Chowdhury. Patient-Inclusive Recruitment in Inflammatory Bowel Disease Trials: Key Takeaways From the 2025 Strategic Alliance for Intercultural Advocacy in GI-American Gastroenterological Association Asian Clinical Research Roundtable , Clinical Gastroenterology & Hepatology, 24(5): 2026,1209-1214

Sehgal P, Khanna T, Profka K, Pickett-Blakely O, Nandi N, Rashid F, Bewtra M, Lewis J, Lichtenstein G, Aberra F. Safety and clinical effectiveness of GLP1 agonists in inflammatory bowel disease patients. , Clin Gastroenterol Hepatol, 25: 2025,S1542-3565(25)00073-4.

Elias S, Nandi N, Grover L, Fourie S, Newman KL Addressing Factors that Impact Sexual Well-Being and Intimacy in IBD Patients , Curr Gastroenterol Rep: 2025,1-10

Brittaney Bonhomme, BS, Neilanjan Nandi, MD, †, Shivali Berera, MD, Helen Lee, MD, Galen Leung, MD, Chung SangTse, MD, Alexandra Weiss, MD, Lisa Nessel, MSS, MLSP, Yue Ren, MA, Hongzhe Li, PhD, Faten N. Aberra, MD, MSCE, James D. Lewis, MD, MSCE Greater Fatigue and Reduced Neurocognitive Speed With Symptomatic Crohn’s Disease. , Crohn's & Colitis 360, 7(1): 2024,1-12

Sehgal P, Khanna T, Profka K, Pickett-Blakely O, Nandi N, Rashid F, Bewtra M, Lewis J, Lichtenstein G, Aberra F. Impact of GLP1 agonists on inflammatory biomarkers in patients with inflammatory bowel disease. , DDW, Poster Sa1950: 2024

Yarur AJ, Long M, Torres J, Nandi N, Cross RK, Abbatemarco AM, Blanco D, Niezychowski W, Crosby C, Wu J, Pradeep G, Goetsch M, Panaccione R. Body mass index does not affect the efficacy and safety of etrasimod in ulcerative colitis patients: a post hoc analysis from the ELEVATE UC clinical program. , American Journal of Gastroenterology., 119(10S): 2024,S1026-S1027

Toiv A, Saleh Z, Alsheik E, Venkat D, Nandi N, Zuchelli T. Digesting Digital Health: A study of appropriateness and readability of Chat GPT generated gastroenterological information. , Clinical and Translational Gastroenterology. , 15(11:e00765): 2024

Charan V, Mukherjee S, Nandi N, Weiss A, Schmoyer C. Evaluating AI-Language models in providing answers for inflammatory bowel disease (IBD) in pregnancy: A comparative analysis of GPT4, BARD and LLAMA2. , DDW, Poster Mo1883: 2024

Allison Ferris, Polina Gaisinskaya, Neilanjan Nandi. Approach to Diarrhea. , Primary Care: Clinics in Office Practice: 2023,447-459

Balasubramaniam M, Nandi N, Aswani-Omprakash T, Sebastian S, Sharma V, Deepak P; South Asian Ibd Alliance Board Of Directors. Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South Asia , Gastroenterology, 163(5): 2022,1145-1150